Atomo Diagnostics (ASX:AT1) 3-Year EBITDA Growth Rate : -4.00% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics 3-Year EBITDA Growth Rate?

Atomo Diagnostics's EBITDA per Share for the six months ended in Dec. 2024 was A$-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Atomo Diagnostics was -4.00% per year. The lowest was -21.10% per year. And the median was -12.55% per year.

Competitive Comparison of Atomo Diagnostics's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Atomo Diagnostics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atomo Diagnostics's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Atomo Diagnostics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Atomo Diagnostics (ASX:AT1) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Atomo Diagnostics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines